Drug Shortage Report for PREGABALIN
Report ID | 211065 |
Drug Identification Number | 02405598 |
Brand name | PREGABALIN |
Common or Proper name | PREGABALIN |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | PREGABALIN |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N02BF |
ATC description | |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-11-17 |
Estimated end date | 2024-02-18 |
Actual end date | 2024-02-20 |
Shortage status | Resolved |
Updated date | 2024-02-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v15 | 2024-02-21 | English | Compare |
v14 | 2024-02-20 | French | Compare |
v13 | 2024-02-20 | English | Compare |
v12 | 2024-02-12 | French | Compare |
v11 | 2024-02-12 | English | Compare |
v10 | 2024-01-30 | French | Compare |
v9 | 2024-01-30 | English | Compare |
v8 | 2024-01-17 | French | Compare |
v7 | 2024-01-17 | English | Compare |
v6 | 2023-12-26 | French | Compare |
v5 | 2023-12-26 | English | Compare |
v4 | 2023-12-01 | French | Compare |
v3 | 2023-12-01 | English | Compare |
v2 | 2023-11-22 | French | Compare |
v1 | 2023-11-22 | English | Compare |
Showing 1 to 15 of 15